Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes – Healio,

As Healio previously reported, the SURPASS clinical trial program, … In trials comparing tirzepatide with other diabetes medications, …, As Healio previously reported, the SURPASS clinical trial program, … In trials comparing tirzepatide with other diabetes medications, …, Read More

Scroll to Top